Growing community of inventors

Medford, MA, United States of America

Michael Frid

Average Co-Inventor Count = 5.39

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Michael FridMaria Vilenchik (4 patents)Michael FridAlexandra Kuznetsova (4 patents)Michael FridYuriy Gankin (3 patents)Michael FridMarc Duey (3 patents)Michael FridMichal Galezowski (1 patent)Michael FridWojciech Czardybon (1 patent)Michael FridCharles-Henry Fabritius (1 patent)Michael FridAgnieszka Dreas (1 patent)Michael FridHelen Segil (1 patent)Michael FridGeorgiy Kachkovskyi (1 patent)Michael FridUrszula Kulesza (1 patent)Michael FridKatarzyna Kucwaj-Brysz (1 patent)Michael FridNial Chase DeMena (1 patent)Michael FridAnna Buda (1 patent)Michael FridAgnieszka Szamborska-Gbur (1 patent)Michael FridAndrzej Dzienia (1 patent)Michael FridHarin Padma-Nathan (1 patent)Michael FridMichael Frid (5 patents)Maria VilenchikMaria Vilenchik (4 patents)Alexandra KuznetsovaAlexandra Kuznetsova (4 patents)Yuriy GankinYuriy Gankin (3 patents)Marc DueyMarc Duey (3 patents)Michal GalezowskiMichal Galezowski (6 patents)Wojciech CzardybonWojciech Czardybon (5 patents)Charles-Henry FabritiusCharles-Henry Fabritius (4 patents)Agnieszka DreasAgnieszka Dreas (2 patents)Helen SegilHelen Segil (1 patent)Georgiy KachkovskyiGeorgiy Kachkovskyi (1 patent)Urszula KuleszaUrszula Kulesza (1 patent)Katarzyna Kucwaj-BryszKatarzyna Kucwaj-Brysz (1 patent)Nial Chase DeMenaNial Chase DeMena (1 patent)Anna BudaAnna Buda (1 patent)Agnieszka Szamborska-GburAgnieszka Szamborska-Gbur (1 patent)Andrzej DzieniaAndrzej Dzienia (1 patent)Harin Padma-NathanHarin Padma-Nathan (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Felicitex Therapeutics, Inc. (4 from 4 patents)

2. Selvita S.a. (1 from 5 patents)

3. Vella Bioscience, Inc. (1 from 1 patent)


5 patents:

1. 11717495 - Use of cannabinoids in treating anti-depressant-induced female sexual dysfunction

2. 11202779 - Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitors

3. 10577365 - Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases

4. 10322128 - Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitors

5. 10314843 - Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosis

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…